Indegene iON Overview
Indegene-Ion offers healthcare solutions using AI and data analytics. This platform improves efficiency and patient outcomes for healthcare providers.
Use Cases
Customers recommend Business Development, Engaging And Following Up, Direct Marketing, as the business use cases that they have been most satisfied with while using Indegene iON.
Business Priorities
Launch New Products is the most popular business priority that customers and associates have achieved using Indegene iON.
Indegene iON Use-Cases and Business Priorities: Customer Satisfaction Data
Indegene iON works with different mediums / channels such as Omnichannel.
Peer review evidence (same sources as the product rating summary)
"...Business Development Lead Chip has over 20 years of experience advancing brands and driving profitability across a broad range of industries. ..." Creative Services & Content Strategy
"...iON leverages Indegene IP including multichannel marketing engagement automation,..." Creative Services & Content Strategy
"...Before Rosetta, Jamie spent 14 years at MRM Worldwide, McCann Worldgroup s digital and direct marketing agency...." Creative Services & Content Strategy
Indegene iON Customer wins, Customer success stories, Case studies
Why is Indegene iON the best choice for Business Development?
What benefits does Indegene iON offer for Engaging And Following Up?
Indegene iON Features
- Low
- Medium
- High
| FEATURE | RATINGS AND REVIEWS |
|---|---|
| Analytics | Read Reviews (9) |
| Custom Reports | Read Reviews (6) |
| CAPABILITIES | RATINGS AND REVIEWS |
|---|---|
| Analytics | Read Reviews (9) |
| Custom Reports | Read Reviews (6) |
Software Failure Risk Guidance
?for Indegene iON
Top Failure Risks for Indegene iON
Indegene News
Indegene Crosses ?3, 500 Crore Revenue Milestone in FY26, Q4 Marks ...
Indegene reported a significant financial milestone, surpassing 3,500 crore in revenue for FY26, with Q4 marking its first 1,000 crore quarter. The company achieved a 23.6% year-on-year revenue growth in INR terms. Despite a one-time TCPA settlement impacting reported PAT, adjusted PAT grew by 12.7%. Indegene's customer base expanded, with notable GenAI-powered engagement wins and a completed BioPharm integration. The board proposed a 12.5% dividend increase.
Indegene Q4 Net Profit Drops to ?797M Despite 32.8% Revenue Growth ...
Indegene reported a 32.8% increase in Q4 FY26 revenue to 10,034M, but net profit fell to 797M. The company achieved a full-year revenue of 35,105M, marking a 23.6% growth. The board proposed a final dividend of 2.25 per share, a 12.5% rise. An earnings call recording is available.
Indegene Q4 net profit falls 32% despite record ?1, 003 crore revenue, declares dividend
Indegene reported a 32.2% decline in Q4 net profit to 79.7 crore despite achieving record quarterly revenue of 1,003.4 crore, marking its first time surpassing 1,000 crore. The company declared a final dividend of 2.25 per share. For FY26, revenue rose 23.6% to 3,510.5 crore, with adjusted EBITDA up 20.8% to 679.3 crore. Indegene secured significant deals, including one with an ACV over $3 million.
Indegene Healthcare UK Limited Completes Asset Purchase Agreement Worth ...
Indegene Healthcare UK Limited, a subsidiary of Indegene Limited, completed a Trade and Asset Purchase Agreement with Trilogy Writing and Consulting Limited for GBP 1,90,679. This internal group consolidation involves acquiring trade and business assets between entities wholly owned by Indegene, aligning with SEBI regulations.
Indegene Profile
Company Name
Indegene
Company Website
https://www.indegene.com/HQ Location
Princeton, New Jersey
Employees
5001-10000
Social
Financials
PRIVATE
